AU2003288788B2 - Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae - Google Patents

Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae Download PDF

Info

Publication number
AU2003288788B2
AU2003288788B2 AU2003288788A AU2003288788A AU2003288788B2 AU 2003288788 B2 AU2003288788 B2 AU 2003288788B2 AU 2003288788 A AU2003288788 A AU 2003288788A AU 2003288788 A AU2003288788 A AU 2003288788A AU 2003288788 B2 AU2003288788 B2 AU 2003288788B2
Authority
AU
Australia
Prior art keywords
clpp
pneumoniae
clpl
mutant
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003288788A
Other languages
English (en)
Other versions
AU2003288788A1 (en
Inventor
Mu-Hyeon Choi
Hyeok-Young Kwon
Abiodun David Ogunniyi
James Cleland Paton
Dong-Kwon Rhee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation and Commercial Partners Pty Ltd
Sungkyunkwan University
Original Assignee
Adelaide Research and Innovation Pty Ltd
Sungkyunkwan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adelaide Research and Innovation Pty Ltd, Sungkyunkwan University filed Critical Adelaide Research and Innovation Pty Ltd
Publication of AU2003288788A1 publication Critical patent/AU2003288788A1/en
Application granted granted Critical
Publication of AU2003288788B2 publication Critical patent/AU2003288788B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2003288788A 2003-12-31 2003-12-31 Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae Ceased AU2003288788B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2003/002929 WO2005063283A1 (en) 2003-12-31 2003-12-31 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
AU2003288788A1 AU2003288788A1 (en) 2005-07-21
AU2003288788B2 true AU2003288788B2 (en) 2007-02-15

Family

ID=34737821

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003288788A Ceased AU2003288788B2 (en) 2003-12-31 2003-12-31 Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae

Country Status (4)

Country Link
US (1) US20080292662A1 (enExample)
JP (2) JP4646806B2 (enExample)
AU (1) AU2003288788B2 (enExample)
WO (1) WO2005063283A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
EP2910647A1 (en) 2008-12-30 2015-08-26 Gen-Probe Incorporated Compositions, kits and related methods for the detection and/or monitoring of listeria
EP2475385A1 (en) 2009-09-10 2012-07-18 Novartis AG Combination vaccines against respiratory tract diseases
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
US20150132339A1 (en) 2012-03-07 2015-05-14 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
US10702596B2 (en) * 2017-07-05 2020-07-07 Inventprise, Llc Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) * 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
CA2315880A1 (en) * 1997-12-31 1999-07-15 Stressgen Biotechnologies Corporation Streptococcal heat shock proteins of the hsp60 family

Also Published As

Publication number Publication date
WO2005063283A1 (en) 2005-07-14
JP2005194264A (ja) 2005-07-21
AU2003288788A1 (en) 2005-07-21
JP4646806B2 (ja) 2011-03-09
JP2007528839A (ja) 2007-10-18
US20080292662A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
US8728490B2 (en) Streptococcus suis vaccines and diagnostic tests
Kwon et al. Effect of heat shock and mutations in ClpL and ClpP on virulence gene expression in Streptococcus pneumoniae
Wessels et al. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci
Balachandran et al. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae
Cao et al. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP
JP2008022856A (ja) 肺炎連鎖球菌由来の核酸及びタンパク質
KR20010104693A (ko) 신규한 스트렙토코커스 항원
US11992522B2 (en) Attenuating bacterial virulence by attenuating bacterial folate transport
US20080219960A1 (en) Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria
AU2003288788B2 (en) Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae
WO2012009774A2 (pt) Microrganismos recombinantes, métodos de preparação de linhagens vacinais, antígenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia
KR101066951B1 (ko) 재조합 세포내 병원체 면역원성 조성물 및 사용 방법
US8828409B2 (en) Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae
DK2256185T3 (en) Heterologous protection against Pasteurella multocida, using the P. multocida fur cells and protein extracts of the outer membrane thereof
KR100814616B1 (ko) 재조합 폐렴구균 ClpP 단백질을 포함하는 백신
KR20050071323A (ko) 재조합 폐렴구균 ClpP 단백질을 포함하는 백신

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired